ALAN JAY FRANKLIN, M.D., PHD
Medical Practice at Dauphin St, Mobile, AL

License number
Alabama 00026319
Category
Medical Practice
Type
Ophthalmology
License number
Alabama ME93012
Category
Medical Practice
Type
Ophthalmology
License number
Alabama 19476
Category
Medical Practice
Type
Ophthalmology
Address
Address 2
3290 Dauphin St SUITE 302, Mobile, AL 36606
5150 N Davis Hwy, Pensacola, FL 32503
Phone
(850) 476-6759
(850) 484-5222 (Fax)

Personal information

See more information about ALAN JAY FRANKLIN at radaris.com
Name
Address
Phone
Alan Franklin
400 NW 1St Ave, Gainesville, FL 32601
(352) 316-3056
Alan Franklin
3081 NW 69Th Ter, Miami, FL 33147
(305) 318-3273
Alan Franklin, age 63
3030 Tiger Creek Trl, Lake Wales, FL 33898
Alan Franklin, age 60
2 Drury Ln, Mobile, AL 36608
(251) 344-9701
Alan Franklin
259 S Cypress Rd APT 538, Pompano Beach, FL 33060

Professional information

See more information about ALAN JAY FRANKLIN at trustoria.com
Alan Jay Franklin Photo 1
Alan Jay Franklin, Mobile AL

Alan Jay Franklin, Mobile AL

Specialties:
Ophthalmology
Work:
Vision America of Mobile
3290 Dauphin St, Mobile, AL 36606 Retina Specialty Institute Mobile
601 Providence Park Dr E, Mobile, AL 36695 Southeastern Retina Assoc
979 E 3Rd St, Chattanooga, TN 37403 Retina Specialists
5150 N Davis Hwy, Pensacola, FL 32503 TRI County Eye Clinic Gulfport
15122 Dedeaux Rd, Gulfport, MS 39503 Tri-County Eye Clinic
431 Bertucci Blvd, Biloxi, MS 39531 Vision Partners
27961 Us Highway 98, Daphne, AL 36526 Sunil Gupta MD LLC
109 Millsaps Dr, Hattiesburg, MS 39402 Sunil Gupta, MD
2000 Lewis Turner Blvd, Fort Walton Beach, FL 32547 Alabama Retina Specialists PC
3016 S Alabama Ave, Monroeville, AL 36460
Education:
Medical College of Ohio (1990) Internal Medicine


Alan J Franklin Photo 2
Dr. Alan J Franklin, Mobile AL - MD (Doctor of Medicine)

Dr. Alan J Franklin, Mobile AL - MD (Doctor of Medicine)

Specialties:
Ophthalmology
Address:
Vision America of Mobile
3290 Dauphin St SUITE 401, Mobile 36606
(251) 471-3309 (Phone)
Vision Partners
601 Providence Park Dr E, Mobile 36695
(251) 650-2010 (Phone)
5150 N Davis Hwy, Pensacola 32503
(251) 970-5565 (Phone)
Certifications:
Ophthalmology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English, French
Hospitals:
Vision America of Mobile
3290 Dauphin St SUITE 401, Mobile 36606
Vision Partners
601 Providence Park Dr E, Mobile 36695
5150 N Davis Hwy, Pensacola 32503
Baptist Hospital
1000 West Moreno St, Pensacola 32501
Bay Medical Center
615 North Bonita Ave, Panama City 32401
Providence Hospital
6801 Airport Blvd, Mobile 36685
Sacred Heart Hospital
401 West Mohawk Dr, Tomahawk 54487
South Baldwin Regional Medical Center
1613 North Mckenzie St, Foley 36535
Education:
Medical School
Medical College Of Ohio
Graduated: 1990
Vanderbilt University
Graduated: 1994
Saint Louis University
Graduated: 1997
University Ia
Graduated: 1999


Alan Franklin Photo 3
Physician And Surgeon At Retina Specialty Institute

Physician And Surgeon At Retina Specialty Institute

Position:
Physician and Surgeon at Retina Specialty Institute
Location:
Mobile, Alabama Area
Industry:
Medical Practice
Work:
Retina Specialty Institute - Physician and Surgeon RFE Pharma 2005 - 2010 - CMO
Education:
ccds


Alan Franklin Photo 4
Cai-Based Systems And Methods For The Localized Treatment Of Ocular And Other Diseases

Cai-Based Systems And Methods For The Localized Treatment Of Ocular And Other Diseases

US Patent:
8614235, Dec 24, 2013
Filed:
Jul 13, 2011
Appl. No.:
13/181847
Inventors:
Gary Robinson - Framingham MA, US
Gideon Shapiro - Gainesville FL, US
Alan J. Franklin - Mobile AL, US
Simona Jurczyk - Gainesville FL, US
Assignee:
RFE Pharma LLC - Framingham MA
International Classification:
A61K 31/41
US Classification:
514359, 514912
Abstract:
The subject invention provides CAI compounds and formulations thereof, and methods for their use in the localized treatment of non-life threatening diseases. Formulations of CAI compounds of the subject invention include CAI free base and CAI prodrug microcrystallines, microparticles, emulsions, and the like. The subject invention further provides methods for treating non-life threatening diseases using the CAI compounds of the invention (i. e. , novel delivery systems and combination therapies) that are effective and are associated with little or no adverse side effects.


Alan Franklin Photo 5
Cai-Based Systems And Methods For The Localized Treatment Of Ocular And Other Diseases

Cai-Based Systems And Methods For The Localized Treatment Of Ocular And Other Diseases

US Patent:
2006011, Jun 1, 2006
Filed:
Sep 26, 2005
Appl. No.:
11/235795
Inventors:
Gary Robinson - Framingham MA, US
Gideon Shapiro - Gainesville FL, US
Alan Franklin - Mobile AL, US
Simona Jurczyk - Gainesville FL, US
International Classification:
A61K 31/4192
US Classification:
514359000
Abstract:
The subject invention provides CAI compounds and formulations thereof, and methods for their use in the localized treatment of non-life threatening diseases. Formulations of CAI compounds of the subject invention include CAI free base and CAI prodrug microcrystallines, microparticles, emulsions, and the like. The subject invention further provides methods for treating non-life threatening diseases using the CAI compounds of the invention (i.e., novel delivery systems and combination therapies), that are effective and are associated with little or no adverse side effects.


Alan Franklin Photo 6
Cai-Based Systems And Methods For The Localized Treatment Of Ocular And Other Diseases

Cai-Based Systems And Methods For The Localized Treatment Of Ocular And Other Diseases

US Patent:
2014007, Mar 20, 2014
Filed:
Nov 19, 2013
Appl. No.:
14/083794
Inventors:
Gideon Shapiro - Gainesville FL, US
Alan J. Franklin - Mobile AL, US
Simona Jurczyk - Gainesville FL, US
Assignee:
RFE Pharma LLC - Framingham MA
International Classification:
A61K 31/4192, A61K 9/00, A61K 45/06, A61K 39/395, A61K 31/7088
US Classification:
4241331, 514359, 514 44 R
Abstract:
The subject invention provides CAI compounds and formulations thereof, and methods for their use in the localized treatment of non-life threatening diseases. Formulations of CAI compounds of the subject invention include CAI free base and CAI prodrug microcrystallines, microparticles, emulsions, and the like. The subject invention further provides methods for treating non-life threatening diseases using the CAI compounds of the invention (i.e., novel delivery systems and combination therapies), that are effective and are associated with little or no adverse side effects.